Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.
The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.
By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.
United Airlines has already begun flying Pfizer’s COVID-19 vaccine into position — including trips to and from locations in the U.S. and Europe — in anticipation of approval by the Food and Drug Administration and other regulators, according to a report.
The first charter flights are part of Pfizer’s efforts to move quickly once approvals are granted, the Wall Street Journal reported.
Pfizer has final vaccine assembly centers in Kalamazoo, Michigan, and in Purrs, Belgium, and runs distribution storage sites in Pleasant Prairie, Wis., and Karlsruhe, Germany, the paper said.
German vials in spotlight as COVID-19 vaccine nears
NOVEMBER 25, 2020
by Michelle Fitzpatrick
As expectations grow that the first COVID-19 jabs will be administered in a matter of weeks, German glassmaker Schott is quietly doing what it has been for months: churning out vials that will hold the vaccine.
The 130-year-old company, whose founder Otto Schott invented the high-quality borosilicate glass favoured by the pharma industry, has been working round the clock to meet unprecedented demand.
Already it has delivered millions of the little bottles to vaccine makers involved in COVID-19 trials, who have already started filling them so they can be shipped out the minute regulators give the okay.
... Schott is supplying vials for three-quarters of the more than 100 coronavirus vaccine trials worldwide.
... To keep production moving, workers are churning out vials 24 hours a day, a typical pace in the sector, and outsiders are banned from the premises to minimise the risk of coronavirus infections.
